ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 209 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $785,000 | -52.3% | 56,552 | -3.5% | 0.00% | -50.0% |
| Q4 2021 | $1,644,000 | -26.7% | 58,605 | -11.2% | 0.01% | -25.0% |
| Q3 2021 | $2,242,000 | -17.4% | 65,967 | -0.7% | 0.01% | -20.0% |
| Q2 2021 | $2,714,000 | +57.9% | 66,427 | +55.6% | 0.01% | +42.9% |
| Q1 2021 | $1,719,000 | -27.5% | 42,704 | +6.5% | 0.01% | -36.4% |
| Q4 2020 | $2,371,000 | +62.2% | 40,092 | +33.4% | 0.01% | +37.5% |
| Q3 2020 | $1,462,000 | +11.4% | 30,064 | +10.8% | 0.01% | +14.3% |
| Q2 2020 | $1,312,000 | +96.7% | 27,128 | +12.9% | 0.01% | +40.0% |
| Q1 2020 | $667,000 | +297.0% | 24,027 | +328.5% | 0.01% | +400.0% |
| Q4 2019 | $168,000 | -6.1% | 5,607 | -3.3% | 0.00% | 0.0% |
| Q3 2019 | $179,000 | +645.8% | 5,800 | +1060.0% | 0.00% | – |
| Q2 2019 | $24,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |